Revive Therapeutics Ltd.
RVV
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -71.83% | -75.58% | -92.58% | -98.11% | -95.83% |
| Total Receivables | -- | 5,640.00% | -52.13% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.49% | -44.58% | -67.01% | -85.14% | -32.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.86% | -47.48% | -51.35% | -80.00% | -81.03% |
| Total Current Assets | 37.79% | -33.14% | -79.25% | -93.98% | -91.85% |
|
|
|||||
| Total Current Assets | 37.79% | -33.14% | -79.25% | -93.98% | -91.85% |
| Net Property, Plant & Equipment | -16.67% | -28.57% | -25.00% | -25.00% | -33.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -24.63% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -96.98% | -97.18% | -97.59% | -98.07% | -30.99% |
|
|
|||||
| Total Accounts Payable | 26.54% | 22.91% | 4.22% | 2.98% | 0.29% |
| Total Accrued Expenses | 4.00% | 32.30% | 27.41% | 20.99% | 22.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 21.25% | 24.85% | 8.83% | 6.09% | 2.68% |
|
|
|||||
| Total Current Liabilities | 21.25% | 24.85% | 8.83% | 6.09% | 2.68% |
| Long-Term Debt | 11.40% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.87% | 1.04% | -0.68% | 0.17% | -1.87% |
| Total Liabilities | 20.61% | 26.45% | 10.61% | 7.92% | 4.43% |
|
|
|||||
| Common Stock & APIC | 6.88% | 5.73% | -2.28% | 0.81% | -5.63% |
| Retained Earnings | -19.45% | -21.68% | -12.73% | -17.05% | -0.13% |
| Treasury Stock & Other | -76.40% | 6.11% | -1.93% | 0.35% | -5.79% |
| Total Common Equity | -169.93% | -161.37% | -150.24% | -147.95% | -42.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -169.93% | -161.37% | -150.24% | -147.95% | -42.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -169.93% | -161.37% | -150.24% | -147.95% | -42.98% |
|
|
|||||